Well Told Grants

Federal grant recipients / Minnesota

Federal grants to Luminary Therapeutics, Inc.

Minneapolis, Minnesota · Small businesses · UEI MNKBAEZHWJS1

Luminary Therapeutics, Inc. in Minneapolis, Minnesota received $6.6 million in federal grants from fiscal 2021 to 2025, across 5 awards. Its largest program was ADVANCED RESEARCH PROJECTS AGENCY for HEALTH (ARPA-H), with $3.7 million. In fiscal 2025 it was awarded $5.1 million.

From USAspending.gov award records, updated November 7, 2026.

By year

Federal grants to Luminary Therapeutics, Inc. by fiscal year
Fiscal yearAwardsAmount
FY 20211$399,658
FY 20220$0
FY 20232$696,991
FY 20241$396,172
FY 20252$5.1 million

An award funded in several years counts in each of them, so yearly awards add up to more than the five-year total.

Programs that fund Luminary Therapeutics, Inc.

Every program, fiscal 2021 to 2025
ProgramAwardsAmount
ADVANCED RESEARCH PROJECTS AGENCY for HEALTH (ARPA-H) 93.3841$3.7 million
Cancer Treatment Research 93.3953$2.7 million
Allergy and Infectious Diseases Research 93.8551$299,770

Awarding agencies

AgencyAwardsAmount
Department of Health and Human Services5$6.6 million

Largest awards

The 5 largest awards by money obligated in fiscal 2021 to 2025
AwardProgramFirst actionAmount
ΓΔ car t-cellular vaccine for solid cancers - solid tumors, such as colorectal cancer (CRC) and lung adenocarcinoma (LUAD), present a formidable challenge in cancer treatment. While chimeric antigen receptor (CAR) t-cell therapies have achieved remarkable success in blood cancers, their effectivenes
ASST_NON_AY1AX000075_075 on USAspending
ADVANCED RESEARCH PROJECTS AGENCY for HEALTH (ARPA-H)January 27, 2025$3.7 million
Allogeneic baff ligand based car t cells as a novel therapy for b cell malignancies - abstract since the first fda approval of chimeric antigen receptor (CAR) t cell therapy in 2017, the use of engineered t cells expressing specific cars to treat cancer has generated durable cures for many patients.
ASST_NON_R44CA278021_075 on USAspending
Cancer Treatment ResearchJune 30, 2023$1.9 million
An allogeneic gamma/delta armored dual-targeting car with split costimulatory domains to target epithelial ovarian carcinoma - abstract car t cell therapies have produced robust remissions in several hematological malignancies. However, they have not achieved the same success against solid tumors. T
ASST_NON_R43CA291415_075 on USAspending
Cancer Treatment ResearchSeptember 13, 2024$399,256
Simultaneous targeting of tumor and stroma cells to enhance solid tumor car-t cell therapy - abstract the use of t cells engineered to express specific chimeric antigen receptors (CARS) to treat cancer has generated durable cures for many types of cancer and resulted in the first fda approved car-t
ASST_NON_R43CA254820_075 on USAspending
Cancer Treatment ResearchJuly 19, 2021$396,574
Allogeneic baff ligand based car t-cells as a novel therapy for systemic lupus erythematous - abstract systemic lupus erythematosus (SLE) is a complex, chronic autoimmune disease with no cure which affects 1.5 million americans. Sle is a rheumatic disease which can lead to severe organ dysfunction,
ASST_NON_R43AI179375_075 on USAspending
Allergy and Infectious Diseases ResearchAugust 1, 2023$299,770

Amounts are net obligations: money committed, minus any amounts taken back. They are not payments. See how our data works.

Questions people ask

How much federal grant money does Luminary Therapeutics, Inc. get?

$6.6 million in 5 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.

Which agency gives Luminary Therapeutics, Inc. the most?

The Department of Health and Human Services, with $6.6 million in 5 awards.

What is Luminary Therapeutics, Inc.'s largest federal grant?

$3.7 million under ADVANCED RESEARCH PROJECTS AGENCY for HEALTH (ARPA-H), with its first action in the period on January 27, 2025. That counts only the money obligated in fiscal 2021 to 2025.

Which federal programs fund Luminary Therapeutics, Inc.?

Its largest are ADVANCED RESEARCH PROJECTS AGENCY for HEALTH (ARPA-H), Cancer Treatment Research and Allergy and Infectious Diseases Research.

Other grant recipients in Minneapolis

Largest federal grant recipients in Minnesota · Federal grants in Minnesota